Market Analysis: Global Preclinical Imaging Market
The global preclinical imaging market accounted to USD 675.0 million in 2016 growing at a CAGR of 6.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition: Global Preclinical Imaging Market
Preclinical imaging (In-VIVO) is basically used in live animal research for drug development. Preclinical imaging is also used to observe the treatment reaction for early signs of effectiveness. The technological development of in vivo imaging offers an opportunity for reviewing disease at the molecular level in a quantitative way. In vivo imaging acts as a bridge between in vitro exploratory and in vivo clinical research which allows the direct and fast transfer of preclinical studies on animal models to clinical investigation in man.
Major Market Drivers and Restraints:
- Technological Progressions
- Increasing Amount of Public-Private Initiatives
- Strict Rules Governing Preclinical Research
- Developing Markets to Offer Fresh Growing Opportunities
- Technological and Procedural Restrictions
Market Segmentation: Global Preclinical Imaging Market
By modalitythe global preclinical imaging market is segmentedinto Optical Imaging Systems, Nuclear Imaging Systems, Micro-Ultrasound,Photoacoustic Imaging Systems,Micro-MRI,Micro-CT,Magnetic Particle Imaging (MPI) Systems,and Photoacoustic Imaging Systems.
Optical Imaging Systems is again bifurcated into Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, and (Optical + X-Ray)/ (Optical + Ct) Systems.
Nuclear Imaging Systems is again bifurcated intoMicro-PET Systems, Micro-Spect Systems andTrimodality (Spect/PET/CT) Systems.Micro-PET Systems is again divided into Standalone PET Systems, PET/CT Systems, and PET/MRI Systems. Micro-Spect Systems are again divided intoStandalone Spect Systems, Spect/CT Systems, and Spect/MRI Systems.
By product the global preclinical imaging market is segmented into Computed Tomography (CT) imaging, medical devices, Magnetic Resonance Imaging (MRI)imaging,Positron Emission Tomography/ Single Photon Emission Computed Tomography (PET/SPECT)imaging, multi-modal imaging, optical imaging, and ultrasound imaging.
On the basis ofthe application global preclinical imaging market is segmented intoresearch & development, and drug discovery.
On the basis of end-user the global preclinical imaging market is segmented into pharmaceutical companies, research institutes, and biotech companies.
On the basis of geography, global preclinical imaging market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Preclinical Imaging Market
The global preclinical imaging market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of preclinical imaging market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Preclinical Imaging Market
Some of the major players operating in global preclinical imaging market areAgilent Technologies, MILabs B.V., Aspect Imaging, Trifoil Imaging, Siemens HealthcarePrivate Limited, Fujifilm Holdings Corporation, Bruker, MR Solutions, Capintec, Berthold Technologies, INDEC BioSystems, Hitachi Medical, LI-COR Biosciences, Mediso Medical Imaging Systems, Angstrom Advanced Inc., Kubtec X-Ray, Miltenyi Biotec GMBH, Naviscan, PerkinElmer, and Thermo Fisher Scientificamong others
Research Methodology: Global Preclinical Imaging Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or drop down your enquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.